Company Profile
Kendall Capital Partners is a next-generation venture capital firm headquartered in Boston, investing in early-to-commercial stage life sciences and healthcare companies solving pressing medical challenges. They focus on disruptive scientific breakthroughs like gene & cell therapies, next-gen immunotherapies, and advanced drug delivery.
News & Signals (0)
No linked news activity found for this company.
Investor Listings
No investor listings assigned to this company yet.